Skip to main content

Advertisement

SpringerLink
Log in

Extrarenal complications of granulomatosis with polyangiitis (GPA)  and microscopic polyangiitis (MPA) and their impact on the outcome of the patients

  • Commentary
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nguyen Y, Pagnoux C, Karras A et al (2020) Microscopic polyangiitis: clinical characteristics and long-term outcomes of 378 patients from the French vasculitis study group registry. J Autoimmun 112:102467. https://doi.org/10.1016/j.jaut.2020.102467

    Article  CAS  PubMed  Google Scholar 

  2. Holle J, Gross WL, Latza U et al (2011) Improved outcome of 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Athritis Rheumatol 63:257–266

    Article  Google Scholar 

  3. Millet A, Pederzoli-Ribeil M, Guillevin L et al (2013) Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis 72:1273–1279

    Article  CAS  Google Scholar 

  4. Schönermarck U, Lamprecht P, Csernok E et al (2001) Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 40:178–184

    Article  Google Scholar 

  5. Schirmer JH, Wright MN, Herrmann K et al (2016) Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis With polyangiitis (Wegener’s) is a clinically distinct subset of ANCA-associated vasculitis: a retrospective analysis of 315 patients from a German vasculitis referral center. Arthritis Rheumatol 68:2953–2963

    Article  CAS  Google Scholar 

  6. Flossmann O, Berden A, de Groot K et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488–494

    Article  Google Scholar 

  7. Kronbichler A, Shin JI, Lee KH et al (2020) Clinical associations of renal involvement in ANCA-associated vasculitis. Autoimmun Rev 19:102495

    Article  CAS  Google Scholar 

  8. Mahr A, Katsahian S, Varet H et al (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis 72:1003–1010

    Article  Google Scholar 

  9. Basu N, McClean A, Harper L et al (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford) 53:953–956

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic

    Vladimir Tesar & Zdenka Hruskova

Authors
  1. Vladimir Tesar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zdenka Hruskova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vladimir Tesar.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article doesnot contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 20 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tesar, V., Hruskova, Z. Extrarenal complications of granulomatosis with polyangiitis (GPA)  and microscopic polyangiitis (MPA) and their impact on the outcome of the patients. J Nephrol 35, 1065–1068 (2022). https://doi.org/10.1007/s40620-022-01250-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-022-01250-y

Search

Navigation